Attract talent




Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.


Add photos to showcase Numab’s culture


Add Numab’s values

Insider experiences

Share your experience of working at Numab

David Urech
Chief Executive Officer
Oliver Middendorp
Chief Business Officer
Peter Lichtlen
Chief Medical Officer
Sebastian Meyer
Chief Operating Officer
Roland Helfenstein
Chief Financial Officer
Daniel Snell
VP, Translational Sciences
Tea Gunde
VP, Discovery
Stefan Warmuth
VP, Protein Engineering & CMC
Taryn Losch Beridon
VP, Clinical Operations & Regulatory Affairs

Add your teams to show how people work together at Numab

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.